Celerion Revenue and Competitors
Estimated Revenue & Valuation
- Celerion's estimated annual revenue is currently $323.9M per year.
- Celerion's estimated revenue per employee is $321,600
Employee Data
- Celerion has 1007 Employees.
- Celerion grew their employee count by 3% last year.
Celerion's People
| Name | Title | Email/Phone |
|---|---|---|
1 | CFO | Reveal Email/Phone |
2 | Executive Director, Strategic Account Development | Reveal Email/Phone |
3 | EVP, Global Clinical Research | Reveal Email/Phone |
4 | VP, Data Management and Biometrics | Reveal Email/Phone |
5 | VP, Drug Development Services | Reveal Email/Phone |
6 | VP, Global Head Quality Assurance | Reveal Email/Phone |
7 | VP, Global Scientific Clinical Operations | Reveal Email/Phone |
8 | Senior Director, Lincoln Clinical Site | Reveal Email/Phone |
9 | Director, Proposal and Financial Management, Global Project Management | Reveal Email/Phone |
10 | Senior Director, Biostatistics | Reveal Email/Phone |
Celerion Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $11.3M | 56 | 24% | N/A | N/A |
#2 | $323.9M | 1007 | 3% | N/A | N/A |
#3 | $76.6M | 381 | 9% | N/A | N/A |
#4 | $5.8M | 29 | -15% | N/A | N/A |
#5 | $9.6M | 48 | 0% | N/A | N/A |
#6 | $14.9M | 74 | 9% | N/A | N/A |
What Is Celerion?
Celerion is the premier provider of innovative early stage clinical research solutions. From facilities strategically located around the world, advanced scientific and technological expertise is applied to clinical research (over 730 beds in Phases 0, I and IIa, NDA-enabling clinical pharmacology, ADME), clinical pharmacology sciences, bioanalytical services (discovery through late stage), and drug development services. Celerion has a full spectrum of resources to meet the needs of the pharmaceutical, biotechnology and generic industries for Phase 0 through IIa proof-of-concept studies.
keywords:N/A
N/A
Total Funding
1007
Number of Employees
$323.9M
Revenue (est)
3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Celerion News
This is your first glimpse of the all-new Suzuki Celerio for PH. Suzuki Today - 9:48 AM.
BioPredictive, Cisbio, Celerion, Echosens, NGM Biopharmaceuticals, Gilead, AstraZeneca, Novartis AG, Novo Nordisk A/S, Pfizer, Inc.
Celerion, a global leader in early clinical research services, offers a unique combination of medical expertise, clinical operations experience,...
LINCOLN, Neb., June 1, 2021 /PRNewswire/ -- Celerion is pleased to announce that they are the recipient of the 2021 Life Science Leader annual CRO Leadership Awards in all five award categories. This is the sixth consecutive year that Celerion has so been honored. Well respected within the ph ...
Celerion, a Lincoln, NE-based provider of clinical study solutions to pharmaceutical and biotechnology clients conducting early clinical research, has announced the successful recapitalization of its business through investment by MTS Health Investors, LLC, a New York-based healthcare private eq ...
Other Companies in Lincoln
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $355.2M | 1044 | 8% | N/A |
#2 | $75M | 1138 | N/A | N/A |
#3 | $334.6M | 1138 | 8% | N/A |
#4 | $455.5M | 1205 | 9% | N/A |
#5 | $460.4M | 1218 | 6% | N/A |